DelveInsight’s ‘Tissue Heart Valves / Cardiovascular Prosthetic Devices -Market Insights, Competitive Landscape and Market Forecast - 2025’ report delivers an in-depth understanding of Tissue Heart Valves / Cardiovascular Prosthetic Devices and the historical and forecasted Tissue Heart Valves / Cardiovascular Prosthetic Devices market trends in the US, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.
The Tissue Heart Valves / Cardiovascular Prosthetic Devices market report provides an overview of Tissue Heart Valves / Cardiovascular Prosthetic Devices , reasons to get Tissue Heart Valves / Cardiovascular Prosthetic Devices as well as its advantages and limitations. Additionally, the report provides insight on the Tissue Heart Valves / Cardiovascular Prosthetic Devices market share of the individual Tissue Heart Valves / Cardiovascular Prosthetic Devices devices, current and forecasted Tissue Heart Valves / Cardiovascular Prosthetic Devices market size from 2017 to 2025 segmented by seven major markets. The report also covers the market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market.
Tissue Heart Valves / Cardiovascular Prosthetic Devices Overview
Mechanical heart valve is an artificial heart valve implanted in the patient suffering from diseases such as aortic stenosis or mitral regurgitation. The growing geriatric population and the resulting rise in Hypertensive Vascular Disease (HVD) incidence, regulatory approvals for modern and improved prosthetic heart valves, increased government support for cardiac valve studies, increased awareness of HVD, and a favourable reimbursement scenario for prosthetic heart valves can be attributable to market development. Patients implanted with these devices do not require anticoagulation medication for a long time. Major advantages of tissue heart valves involve easy tolerance by the body and an average life expectancy of more than 15 years. However, their drawback is their durability only up to 10 to 20 years, thereby creating the need for a second replacement surgery. It is expected that the high cost of transcatheter heart valve devices will inhibit the development of the global demand for prosthetic heart valves. In addition, problems related to procedures are also likely to restrict future growth.
Study Period: 2017–2025
Geography Covered
• The US
• EU5 (Germany, France, Italy, Spain and the United Kingdom)
• Japan
List of Companies:
Medtronic plc (Ireland), Edwards Lifesciences Corporation (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (an Abbott Laboratories Company) (U.S.), LivaNova PLC (U.K.), Symetis SA (Switzerland), Jenavalve Technology, Inc. (Germany), CryoLife, Inc. (U.S.), TTK Healthcare Limited (India), Colibri Heart Valve, LLC (U.S.), Lepu Medical Technology Co., Ltd. (China), and Braile Biomédica (Brazil).
Tissue Heart Valves / Cardiovascular Prosthetic Devices - Competitive Analysis
This segment of the report provides a brief competitive analysis of Tissue Heart Valves / Cardiovascular Prosthetic Devices , to help understand the competition in the market. It gives a comparative understanding of the products based on types of wounds.
Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis
This segment illustrates the market of Tissue Heart Valves / Cardiovascular Prosthetic Devices across 7MM and how the market is expected to rise in the study period (2017 to 2025), at a significant CAGR.
KOL- Views
To keep up with the market trends, we take KOLs and SME’s opinion working in Tissue Heart Valves / Cardiovascular Prosthetic Devices domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Tissue Heart Valves / Cardiovascular Prosthetic Devices market trend. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.
Scope of the Report
• The report covers the descriptive overview of Tissue Heart Valves / Cardiovascular Prosthetic Devices , explaining its applications, advantages, and limitations, etc.
• Additionally, an all-inclusive account of the currently available Tissue Heart Valves / Cardiovascular Prosthetic Devices is provided, which will have an impact on the future market of Tissue Heart Valves / Cardiovascular Prosthetic Devices .
• A detailed review of Tissue Heart Valves / Cardiovascular Prosthetic Devices market; historical and forecasted market size is included in the report, covering devices outreach in the 7MM.
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Tissue Heart Valves / Cardiovascular Prosthetic Devices market.
Report Highlights
• The report covers descriptive overview of the Tissue Heart Valves / Cardiovascular Prosthetic Devices , explaining its applications, working mechanism, etc.
• The report provides an insight into the patient population eligible for Tissue Heart Valves / Cardiovascular Prosthetic Devices in the 7 MM, covering the US, EU5 (Germany, Spain, France, Italy, UK) & Japan.
• The report is a comprehensive account of marketed devices present in the Tissue Heart Valves / Cardiovascular Prosthetic Devices market.
• The report also reviews the detailed global historical and forecasted Tissue Heart Valves / Cardiovascular Prosthetic Devices market including assessing the outreach in 7 MM.
• The report helps in developing business strategies by understanding trends shaping and driving the global Tissue Heart Valves / Cardiovascular Prosthetic Devices market.
Tissue Heart Valves / Cardiovascular Prosthetic Devices Report Key Strengths
• 6 Years Forecast
• 7MM Coverage
• Competitive Landscape
• Patient pool
• Market Size
Tissue Heart Valves / Cardiovascular Prosthetic Devices Report Assessment
• Marketed Product profiles
• Key Products and Key Players
• Market Drivers and Barriers
• Market Forecast
• KOL’S views
Key Questions
Market Insights:
• What was the Tissue Heart Valves / Cardiovascular Prosthetic Devices market share (%) distribution in 2017 and how it will look like in 2025?
• What will be the Tissue Heart Valves / Cardiovascular Prosthetic Devices total market Size as well as market Size by devices across the 7MM during the forecast period (2017–2025)?
• What are the key findings pertaining to the market across 7MM and which country will have the largest Tissue Heart Valves / Cardiovascular Prosthetic Devices market Size during the forecast period (2017–2025)?
• At what CAGR, the Tissue Heart Valves / Cardiovascular Prosthetic Devices market is expected to grow in 7mm during the forecast period (2017–2025)?
• What will be the Tissue Heart Valves / Cardiovascular Prosthetic Devices market outlook across the 7mm during the forecast period (2017–2025)?
• What will be the Tissue Heart Valves / Cardiovascular Prosthetic Devices market growth till 2025 and what will be the resultant market size in the year 2025?
• How will the market drivers, barriers and future opportunities affect the market dynamics and a subsequent analysis of the associated trends?
Competitive Landscape:
• What are the current devices available in the Tissue Heart Valves / Cardiovascular Prosthetic Devices market?
• What is the Tissue Heart Valves / Cardiovascular Prosthetic Devices available in the market, their product description, regulatory milestones, product development activities, research and development activities etc.?
• How many key players are developing Tissue Heart Valves / Cardiovascular Prosthetic Devices ?
• What are the key collaborations (Industry–Industry), Mergers and acquisitions, licensing activities related to the Tissue Heart Valves / Cardiovascular Prosthetic Devices ?
• What are the key designations that have been granted for the current Tissue Heart Valves / Cardiovascular Prosthetic Devices ?
• What are the global historical and forecasted market of Tissue Heart Valves / Cardiovascular Prosthetic Devices ?
'
1. Key Insights
2. Executive Summary of Tissue Heart Valves / Cardiovascular Prosthetic Devices
3. Tissue Heart Valves / Cardiovascular Prosthetic Devices : Background and Overview
3.1. Introduction
4. Company Profiles
4.1. Company A
4.1.1. Company Overview
4.1.2 Product Portfolio
4.1.2.1 Product description
4.1.2.2 Regulatory Milestones
4.1.2.3 Research and Development
4.1.2.4 Product Development Activities
4.2. Company B
4.2.1.Company Overview
4.2.2 Product Portfolio
4.2.2.1 Product description
4.2.2.2 Regulatory Milestones
4.2.2.3 Research and Development
4.2.2.4 Product Development Activities
Products detail in the report…
5 Tissue Heart Valves / Cardiovascular Prosthetic Devices : Competitive Analysis
6. Tissue Heart Valves / Cardiovascular Prosthetic Devices Devices: Market Analysis
6.1. Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in the 7MM (2017–2025)
6.1.1. Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in the 7MM by type (2017–2025)
6.1.2. Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in the 7MM by application (2017–2025)
6.1.3. Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in the 7MM by end user (2017–2025)
6.2. Tissue Heart Valves / Cardiovascular Prosthetic Devices : United States Market Analysis (2017–2025)
6.2.1. Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in the US by type (2017-2025)
6.2.2. Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in the US by application (2017-2025)
6.2.3. Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in the US by end user (2017-2025)
6.3. Tissue Heart Valves / Cardiovascular Prosthetic Devices : Germany Market Analysis (2017–2025)
6.3.1. Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in Germany by type (2017-2025)
6.3.2. Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in Germany by application (2017-2025)
6.3.3. Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in Germany by end user (2017-2025)
6.4. Tissue Heart Valves / Cardiovascular Prosthetic Devices : France Market Analysis (2017–2025)
6.3.1. Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in France by type (2017-2025)
6.3.2. Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in France by application (2017-2025)
6.3.3. Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in France by end user (2017-2025)
6.5. Tissue Heart Valves / Cardiovascular Prosthetic Devices : Italy Market Analysis (2017–2025)
6.5.1. Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in Italy by type (2017-2025)
6.5.2. Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in Italy by application (2017-2025)
6.5.3. Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in Italy by end user (2017-2025)
6.6. Tissue Heart Valves / Cardiovascular Prosthetic Devices : Spain Market Analysis (2017–2025)
6.6.1. Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in Spain by type (2017-2025)
6.6.2. Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in Spain by application (2017-2025)
6.6.3. Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in Spain by end user (2017-2025)
6.7. Tissue Heart Valves / Cardiovascular Prosthetic Devices : United Kingdom Market Analysis (2017–2025)
6.7.1. Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in the UK by type (2017-2025)
6.7.2. Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in the UK by application (2017-2025)
6.7.3. Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in the UK by end user (2017-2025)
6.8. Tissue Heart Valves / Cardiovascular Prosthetic Devices : Japan Market Analysis (2017–2025)
6.8.1. Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in Japan by type (2017-2025)
6.8.2. Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in Japan by application (2017-2025)
6.8.3. Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in Japan by end user (2017-2025)
7. Market Drivers
8. Market Barriers
9. Industry Trends
10. KOL’s Views
11. Analyst Views
12. PEST Analysis
13. Appendix
13.1. Bibliography
13.2. Report Methodology
14. DelveInsight Capabilities
15. Disclaimer
16. About DelveInsight
Table 1: Competitive Analysis
Table 2: Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in the 7MM (2017–2025)
Table 3: Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in the 7MM by type (2017–2025)
Table 4: Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in the 7MM by application (2017–2025)
Table 5: Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in the 7MM by end user (2017–2025)
Table 6: Tissue Heart Valves / Cardiovascular Prosthetic Devices : United States Market Analysis (2017–2025)
Table 7: Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in the US by type (2017-2025)
Table 8: Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in the US by application (2017-2025)
Table 9: Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in the US by end user (2017-2025)
Table 10: Tissue Heart Valves / Cardiovascular Prosthetic Devices : Germany Market Analysis (2017–2025)
Table 11: Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in Germany by type (2017-2025)
Table 12: Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in Germany by application (2017-2025)
Table 13: Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in Germany by end user (2017-2025)
Table 14: Tissue Heart Valves / Cardiovascular Prosthetic Devices : France Market Analysis (2017–2025)
Table 15: Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in France by type (2017-2025)
Table 16: Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in France by application (2017-2025)
Table 17: Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in France by end user (2017-2025)
Table 18: Tissue Heart Valves / Cardiovascular Prosthetic Devices : Italy Market Analysis (2017–2025)
Table 19: Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in Italy by type (2017-2025)
Table 20: Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in Italy by application (2017-2025)
Table 21: Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in Italy by end user (2017-2025)
Table 22: Tissue Heart Valves / Cardiovascular Prosthetic Devices : Spain Market Analysis (2017–2025)
Table 23: Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in Spain by type (2017-2025)
Table 24: Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in Spain by application (2017-2025)
Table 25: Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in Spain by end user (2017-2025)
Table 26: Tissue Heart Valves / Cardiovascular Prosthetic Devices : United Kingdom Market Analysis (2017–2025)
Table 27: Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in the UK by type (2017-2025)
Table 28: Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in the UK by application (2017-2025)
Table 29: Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in the UK by end user (2017-2025)
Table 30: Tissue Heart Valves / Cardiovascular Prosthetic Devices : Japan Market Analysis (2017–2025)
Table 31: Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in Japan by type (2017-2025)
Table 32: Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in Japan by application (2017-2025)
Table 33: Tissue Heart Valves / Cardiovascular Prosthetic Devices : Market Analysis in Japan by end user (2017-2025)
Medtronic plc (Ireland), Edwards Lifesciences Corporation (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (an Abbott Laboratories Company) (U.S.), LivaNova PLC (U.K.), Symetis SA (Switzerland), Jenavalve Technology, Inc. (Germany), CryoLife, Inc. (U.S.), TTK Healthcare Limited (India), Colibri Heart Valve, LLC (U.S.), Lepu Medical Technology Co., Ltd. (China), and Braile Biomédica (Brazil).
